You just read:

Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells

News provided by

Boston Biomedical, Inc.

Apr 07, 2011, 05:00 ET